Sunil Singhal
Presidente presso Center For Advanced Retinal & Ocular Therapies
Posizioni attive di Sunil Singhal
Società | Posizione | Inizio | Fine |
---|---|---|---|
Sunlight Fuels Pvt Ltd.
Sunlight Fuels Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Sunlight Fuels Pvt Ltd. is an Indian company that provides business and management consultancy services. The private company is based in New Delhi, India and was founded in 2014. | Direttore/Membro del Consiglio | 25/11/2014 | - |
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners (Research Bridge Partners) is a venture capital firm founded in 2016 by Reid Hoffman. The firm is headquartered in Austin, Texas. | Investitore di Private Equity | 01/03/2021 | - |
Forefront Analytics LLC
Forefront Analytics LLC Investment ManagersFinance Forefront Analytics LLC (Forefront) is an independent asset management firm headquartered in West Conshohocken, Pennsylvania. The firm was founded in 2010 by Christopher Geczy and William Thompson. Forefront provides consulting, investment advisory, and investment management services to ultra-high-net worth individuals and families, investment limited partnerships, trusts, corporations, and other business entities. | Consulente / Consigliere | 01/03/2020 | - |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Direttore/Membro del Consiglio | 01/10/2020 | - |
Independent Dir/Board Member | 01/10/2020 | - | |
Center For Advanced Retinal & Ocular Therapies | Presidente | 01/01/2018 | - |
Storia della carriera di Sunil Singhal
Formazione di Sunil Singhal
Dartmouth College | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
India | 2 |
Posizioni
Director/Board Member | 2 |
Private Equity Investor | 1 |
Consultant / Advisor | 1 |
Settori
Consumer Services | 3 |
Finance | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Forefront Analytics LLC
Forefront Analytics LLC Investment ManagersFinance Forefront Analytics LLC (Forefront) is an independent asset management firm headquartered in West Conshohocken, Pennsylvania. The firm was founded in 2010 by Christopher Geczy and William Thompson. Forefront provides consulting, investment advisory, and investment management services to ultra-high-net worth individuals and families, investment limited partnerships, trusts, corporations, and other business entities. | Finance |
Sunlight Fuels Pvt Ltd.
Sunlight Fuels Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Sunlight Fuels Pvt Ltd. is an Indian company that provides business and management consultancy services. The private company is based in New Delhi, India and was founded in 2014. | Commercial Services |
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners (Research Bridge Partners) is a venture capital firm founded in 2016 by Reid Hoffman. The firm is headquartered in Austin, Texas. | Finance |
Center For Advanced Retinal & Ocular Therapies | |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Health Technology |
- Borsa valori
- Insiders
- Sunil Singhal
- Esperienza